• 3-Deazaadenosine Hydrochloride: Selective SAHH Inhibition in

  2026-07-01

  3-Deazaadenosine hydrochloride is a potent S-adenosylhomocysteine hydrolase inhibitor with a Ki of ~3.9 μM, offering precise modulation of methyltransferase-dependent pathways. Its high purity, robust solubility profile, and validated use in hepatic stellate cell (HSC) models make it a cornerstone for inflammation and cell proliferation research. The compound’s selectivity enables reproducible dissection of methylation mechanisms in fibrosis and related pathologies.

• CUDC-907: Technical Guide for Dual PI3K and HDAC Inhibition

  2026-07-01

  CUDC-907 is a dual PI3K and HDAC inhibitor designed for in vitro research requiring simultaneous modulation of PI3K/AKT and histone deacetylase pathways. It supports mechanistic studies of cell cycle arrest and apoptosis in cancer cell models, but is not suitable for diagnostic or therapeutic use. Use is restricted to controlled laboratory workflows with appropriate quality controls.

• Toremifene in Breast Cancer: Two Decades of Endocrine Therap

  2026-06-30

  This review synthesizes 20 years of clinical experience with toremifene, spotlighting its role as a selective estrogen receptor modulator (SERM) for hormone-sensitive breast cancer. The findings inform biomarker-driven, personalized therapy selection and highlight the clinical implications of pharmacogenomics in endocrine treatment.

• NADH in Mitochondrial Dysfunction: Mechanisms, Models, and T

  2026-06-30

  Explore how reduced nicotinamide adenine dinucleotide (NADH) enables advanced mitochondrial electron transport chain research and disease modeling. This article uniquely bridges molecular mechanism, metabolic modeling, and protocol design for NADH applications in translational science.

• Alternariol Drives Hepatic Stellate Cell Fibrosis via NF-κB

  2026-06-29

  This study provides multi-omics evidence that Alternariol (AOH) and related Alternaria toxins directly induce hepatic stellate cell (HSC) transdifferentiation into myofibroblasts, a key step in liver fibrosis. The findings advance mycotoxin research by mapping the NF-κB, ferroptosis, and autophagy pathways and introducing a laccase-mediated detoxification strategy.

• Recombinant Mouse Sonic Hedgehog: Evidence and Protocols

  2026-06-29

  Recombinant Mouse Sonic Hedgehog (SHH) protein is a validated morphogen essential for limb, brain, and urogenital patterning studies. Its mechanism, purity, and bioactivity benchmarks are well-characterized, supporting rigorous developmental biology research. This article provides verifiable claims, optimal workflow parameters, and clarifies boundaries of use.

• Danazol in Endocrine Research: Applied Workflows & Troublesh

  2026-06-28

  Danazol (Danocrine) serves as a benchmark tool for probing inhibition of steroidogenesis and androgen receptor signaling in both cellular and animal models. Discover optimized protocols, troubleshooting strategies, and translational insights—highlighting how high-purity Danazol from APExBIO accelerates robust, reproducible endocrine research.

• GLT-1 Upregulation Attenuates Neuronal Death via CB1-CREB In

  2026-06-27

  This study elucidates how boosting GLT-1 expression in astrocytes protects neurons after traumatic brain injury by dampening CB1-CREB mediated suppression of glutamate clearance. The findings provide mechanistic clarity on the interplay between endocannabinoid signaling and glutamate homeostasis, pointing toward potential neuroprotective strategies for TBI.

• Applied Use of α-Linolenic Acid in Lipid and Immune Research

  2026-06-26

  Harness the unique versatility of α-Linolenic Acid (ALA) for advanced lipid metabolism and immune modulation studies. This guide demystifies optimized workflows, protocol parameters, and troubleshooting strategies—enabling reproducible, high-impact results in cardiovascular, inflammation, and cancer biology research.

• Gut-Brain Cholinergic Pathways in B. fragilis–Mediated Seizu

  2026-06-26

  Jia et al. present compelling evidence that Bacteroides fragilis exerts antiseizure effects in pediatric epilepsy via enhanced gut-brain cholinergic signaling and intestinal Lactobacillus enrichment. Their integrative use of animal models, clinical trial data, and mechanistic probing delineates a novel microbiota–neural circuit axis with translational potential for refractory epilepsy.

• Puromycin Aminonucleoside: Mechanisms, Solubility, and Prote

  2026-06-25

  Explore the multifaceted role of puromycin aminonucleoside in nephrotic syndrome research, with a focus on advanced solubility profiling and proteomic innovations. This article offers a deeper mechanistic and methodological perspective on this critical reagent, setting it apart from existing content.

• Nebivolol Hydrochloride: Precision Tool for β1-Adrenoceptor

  2026-06-25

  Explore Nebivolol hydrochloride, a highly selective β1-adrenoceptor antagonist, as a gold-standard tool for dissecting cardiovascular signaling pathways. This article delivers scientific depth on its mechanism, practical assay considerations, and critical insights from recent mTOR inhibitor discovery research.

• GLT-1 Upregulation Mitigates TBI by Inhibiting CB1-CREB Path

  2026-06-24

  This study uncovers how upregulating GLT-1 expression in mice after traumatic brain injury (TBI) reduces neuronal apoptosis and cognitive dysfunction by suppressing the CB1-CREB signaling pathway. The findings clarify the mechanistic link between endocannabinoid signaling and glutamate transporter regulation, informing targeted strategies for TBI intervention.

• Topotecan as First-Line Therapy in Small Cell Lung Cancer: A

  2026-06-23

  The reference study systematically evaluates topotecan as a first-line therapy for small cell lung cancer (SCLC), detailing its efficacy, toxicity profile, and mechanistic rationale. Insights from this work have implications for optimizing topoisomerase I inhibitor use across cancer research domains, including colorectal cancer models where agents like Irinotecan (CPT-11) are pivotal.

• ERAD-Hijacking Chimeras Enable Selective Degradation of TM P

  2026-06-23

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule platform that hijacks the endoplasmic reticulum-associated degradation pathway for efficient, selective degradation of transmembrane proteins. This work overcomes longstanding hurdles in targeted protein degradation, with broad implications for membrane protein research and therapeutic development.

455 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page